US Edition
News from MedCity News
If you want to know if MedCity News is credible or reliable, look no further. We rank MedCity News as High factuality. Find out more about our methodology here.
Media Bias Ratings
Average Bias Rating:
Center
Center
byAd Fontes MediaCenter
byMedia Bias/Fact CheckDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top MedCity News News
Chatham, Virginia · Chatham(MedPage Today) -- The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic hives, Novartis announced on Tuesday.
Indicated for adults with stubborn symptoms despite the use of...See the Story
Oral Drug Wins FDA Approval for Chronic Hives
66% Center coverage: 26 sources
Medicare · United StatesThe government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare telehealth access and programs like SNAP. The post How Healthcare Leaders Are Reacting to the Government Shutdown appeared first on MedCity News.See the Story
How Healthcare Leaders Are Reacting to the Government Shutdown
58% Left coverage: 12 sources
